Nasopharyngeal carcinoma: A new synthesis of literature data
Nasopharyngeal carcinoma (NPC) is an epithelial tumor, which develops most frequently
from the lateral pharyngeal recess and holds some complex epidemiological characteristics …
from the lateral pharyngeal recess and holds some complex epidemiological characteristics …
Infantile hemangiomas: an update on pathogenesis and treatment
M Kowalska, W Dębek, E Matuszczak - Journal of clinical medicine, 2021 - mdpi.com
Infantile hemangiomas are the most common benign vascular tumors in infancy. This review
includes an update on the current knowledge on pathogenesis, a discussion on indications …
includes an update on the current knowledge on pathogenesis, a discussion on indications …
Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin
K Rejdak, H Sienkiewicz‐Jarosz… - Medicinal Research …, 2023 - Wiley Online Library
Neurotrophic factors (NTFs) are involved in the pathophysiology of neurological disorders
such as dementia, stroke and traumatic brain injury (TBI), and constitute molecular targets of …
such as dementia, stroke and traumatic brain injury (TBI), and constitute molecular targets of …
Das Infantile Hämangiom: Pathogenese und Wirkmechanismus von propranolol
A Rotter, ZNP de Oliveira - JDDG: Journal der Deutschen …, 2017 - Wiley Online Library
Das infantile Hämangiom (IH) ist der häufigste gutartige Tumor im Kindesalter. Die
Prävalenz beträgt 4% bis 10%. Es ist gekennzeichnet durch eine proliferative schnelle …
Prävalenz beträgt 4% bis 10%. Es ist gekennzeichnet durch eine proliferative schnelle …
[HTML][HTML] The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
A Montoya, A Varela-Ramirez, E Dickerson… - Biomedical journal, 2019 - Elsevier
Background Substantial evidence supports the use of inexpensive β-AR antagonists (beta
blockers) against a variety of cancers, and the β-AR antagonist propranolol was recently …
blockers) against a variety of cancers, and the β-AR antagonist propranolol was recently …
Propranolol induces regression of hemangioma cells via the down‐regulation of the PI3K/Akt/eNOS/VEGF pathway
Background Infantile hemangioma (IH) is a benign vascular neoplasm resulting from the
abnormal proliferation of endothelial cells and pericytes in infants. Propranolol, a non …
abnormal proliferation of endothelial cells and pericytes in infants. Propranolol, a non …
Effectiveness of propranolol in preventing severe retinopathy of prematurity: a comprehensive systematic review and meta-analysis
MA Shafique, A Haseeb, MMN Uddin, B Asghar… - American Journal of …, 2023 - Elsevier
ABSTRACT BACKGROUND One of the most common causes of juvenile blindness that is
avoidable is retinopathy of prematurity (ROP). As more extremely preterm newborns survive …
avoidable is retinopathy of prematurity (ROP). As more extremely preterm newborns survive …
Propranolol therapy for infantile hemangioma: our experience
L Zhang, HW Wu, W Yuan, JW Zheng - Drug design, development …, 2017 - Taylor & Francis
Objective Hemangiomas are the most common benign vascular tumors of infancy. Although
most infantile hemangiomas (IHs) have the ability to involute spontaneously after initial …
most infantile hemangiomas (IHs) have the ability to involute spontaneously after initial …
Propranolol therapy in infantile hemangioma: it is not just about the beta
JC Lee, O Modiri, RW England… - Plastic and …, 2021 - journals.lww.com
Background: Propranolol, a nonselective β-adrenergic receptor antagonist, is approved by
the US Food and Drug Administration to treat problematic infantile hemangiomas, but a …
the US Food and Drug Administration to treat problematic infantile hemangiomas, but a …
Propranolol targets hemangioma stem cells via cAMP and mitogen-activated protein kinase regulation
NCO Munabi, RW England, AK Edwards… - Stem cells …, 2016 - academic.oup.com
Infantile hemangiomas (IHs) are the most common vascular tumor and arise from a
hemangioma stem cell (HemSC). Propranolol has proved efficacious for problematic IHs …
hemangioma stem cell (HemSC). Propranolol has proved efficacious for problematic IHs …